Synergistic effect of olaparib (AZD2281) with combination of cisplatin on PTEN-deficient lung cancer cell lines

被引：0
|
作者：
Minami, Daisuke [1 ]
Takigawa, Nagio [2 ]
Takeda, Hiromasa [3 ]
Takata, Minoru [4 ]
Ichihara, Eiki [1 ]
Hisamoto, Akiko [1 ]
Hotta, Katsyuyuki [1 ]
Tabata, Masahiro [1 ]
Tanimoto, Mitsune [1 ]
Kiura, Katsuyuki [1 ]
机构：
[1] Okayama Univ Hosp, Okayama, Japan
[2] Kawasaki Med Sch, Okayama, Japan
[3] Tottori Municipal Hosp, Tottori, Japan
[4] Kyoto Univ, Kyoto, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4686
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4686
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Anti-cancer effect of sodium pentaborate in combination with cisplatin on lung cancer cell lines
    Deniz, Cansin
    Gedik, Talar
    Yuksel, Busra
    Cebeci, Emre
    Sahin, Fikrettin
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [22] Synergistic effect of paeonol and cisplatin on oesophageal cancer cell lines
    Wan, X. -A.
    Sun, G. -P.
    Wang, H.
    Xu, S. P.
    Wang, Z. -G.
    Liu, S. -H.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 (07) : 531 - 539
  • [23] A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer
    Liu, Joyce F.
    Tolaney, Sara M.
    Birrer, Michael
    Fleming, Gini F.
    Buss, Mary K.
    Dahlberg, Suzanne E.
    Lee, Hang
    Whalen, Christin
    Tyburski, Karin
    Winer, Eric
    Ivy, Percy
    Matulonis, Ursula A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) : 2972 - 2978
  • [24] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines
    Ibrahim, Toni
    Liverani, Chiara
    Mercatali, Laura
    Sacanna, Emanuele
    Zanoni, Michele
    Fabbri, Francesco
    Zoli, Wainer
    Amadori, Dino
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (04) : 1263 - 1270
  • [25] Phase IB study of olaparib (AZD2281) plus gefitinib in EGFR-mutant patients (p) with advanced non-small-cell lung cancer (NSCLC) (NCT01513174/GECP-GOAL).
    Garcia Campelo, Rosario
    Felip, Enriqueta
    Massuti, Bartomeu
    Majem, Margarita
    Carcereny, Enric
    Cardenal, Felipe
    Angel Molina-Vila, Miguel
    Martinez Marti, Alex
    Luis Marti-Ciriquian, Juan
    Alonso-Jaudenes Curbera, Guillermo
    Pallares, Cinta
    Palmero, Ramon
    Carmen Gonzalez-Arenas, Maria
    Mayo-de las Casas, Clara
    Sanchez-Ronco, Maria
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines
    Aoe, K
    Kiura, K
    Ueoka, H
    Tabata, M
    Matsumura, T
    Chikamori, M
    Matsushita, A
    Kohara, H
    Harada, M
    ANTICANCER RESEARCH, 1999, 19 (1A) : 291 - 299
  • [27] ATM-deficient lung, prostate and pancreatic cancer cells are acutely sensitive to the combination of olaparib and the ATR inhibitor AZD6738
    Nicholas R. Jette
    Suraj Radhamani
    Ruiqiong Ye
    Yaping Yu
    Greydon Arthur
    Siddhartha Goutam
    Tarek A. Bismar
    Mehul Kumar
    Pinaki Bose
    Steven Yip
    Michael Kolinsky
    Susan P. Lees-Miller
    Genome Instability & Disease, 2020, 1 (4) : 197 - 205
  • [28] The PARP1 inhibitor olaparib (AZD2281) enhances radiation-induced DNA damage in BRCA1iBRCA2 wild-type head and neck squamous cell carcinoma cell lines
    Frederick, Barbara A.
    Fletcher, Ashley
    Raben, David
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [29] The clinical efficacy of olaparib monotherapy or combination with ceralasertib (AZD6738) in relapsed small cell lung cancer.
    Park, Sehhoon
    Mortimer, Peter G.
    Smith, Simon
    Kim, Heejung
    Jung, Hyun Ae
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Woong-Yang
    Lee, Se-Hoon
    Park, Keunchil
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Cisplatin in Combination with Entinostat exerts Synergistic Antineoplastic Activity in Small Cell Lung Cancer
    Schwendenwein, A.
    Boettiger, K.
    Kovacs, I.
    Barany, N.
    Lang, C.
    Megyesfalvi, Z.
    Grusch, M.
    Kowol, C.
    Rezeli, M.
    Hoetzenecker, K.
    Dome, B.
    Schelch, K.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S537 - S537
12345